2024
Associations Between Prostate Magnetic Resonance Imaging, Genomic Testing, and Treatment for Localized Prostate Cancer
Sundaresan V, Wang R, Long J, Sprenkle P, Seibert T, Loeb S, Cooperberg M, Catalona W, Ma X, Gross C, Leapman M. Associations Between Prostate Magnetic Resonance Imaging, Genomic Testing, and Treatment for Localized Prostate Cancer. Urology Practice 2024, 11: 965-973. PMID: 39196719, DOI: 10.1097/upj.0000000000000679.Peer-Reviewed Original ResearchLocalized prostate cancerClinically localized prostate cancerHigh-risk diseaseProstate MRIProstate cancerTreatment intensificationIntensified treatmentGenomic testingTreated patientsProstate magnetic resonance imagingEnd Results databaseLong-term patient outcomesProstate cancer prognosisRetrospective cohort studyAssociated with decreased oddsRisk stratification toolPrimary study outcomeAssociated with increased oddsMagnetic resonance imagingResults databaseStratification toolTreatment patientsCohort studyRisk strataCancer prognosisUpdated Analysis of Comparative Toxicity of Proton and Photon Radiation for Prostate Cancer
Yu J, DeStephano D, Jeffers B, Horowitz D, Soulos P, Gross C, Cheng S. Updated Analysis of Comparative Toxicity of Proton and Photon Radiation for Prostate Cancer. Journal Of Clinical Oncology 2024, 42: 1943-1952. PMID: 38507655, DOI: 10.1200/jco.23.01604.Peer-Reviewed Original ResearchIntensity-modulated radiation therapyProton beam therapyGU toxicityProstate cancerGI toxicityBenefits of proton beam therapyIntensity-modulated radiation therapy patientsPBT patientsLocalized prostate cancerTreatment-related toxicityComparison of GIStatistically significant differenceRadiation therapyBeam therapySEER-MedicareToxicity of protonProcedure codesComparative effectiveness studiesObservational studyPatientsSignificant differenceCancerMonthsComparing GIProstate
2023
PD10-01 ASSOCIATIONS BETWEEN PROSTATE MRI AND GENOMIC TESTING AND TREATMENT INTENSIFICATION AMONG PATIENTS WITH LOCALIZED PROSTATE CANCER
Leapman M, Wang R, Long J, Sprenkle P, Ma X, Gross C. PD10-01 ASSOCIATIONS BETWEEN PROSTATE MRI AND GENOMIC TESTING AND TREATMENT INTENSIFICATION AMONG PATIENTS WITH LOCALIZED PROSTATE CANCER. Journal Of Urology 2023, 209: e326. DOI: 10.1097/ju.0000000000003250.01.Peer-Reviewed Original ResearchLocalized prostate cancerTreatment intensificationProstate cancerProstate MRIGenomic testingPatientsCancerMRIUse of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation
Leapman M, Wang R, Loeb S, Seibert T, Gaylis F, Lowentritt B, Brown G, Chen R, Lin D, Witte J, Cooperberg M, Catalona W, Gross C, Ma X. Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation. Journal Of Urology 2023, 209: 710-718. PMID: 36753746, DOI: 10.1097/ju.0000000000003159.Peer-Reviewed Original ResearchConceptsIntermediate-risk prostate cancerMixed-effects Poisson regressionPSA testingProstate biopsyProstate cancerEffects Poisson regressionMedicare beneficiariesPoisson regressionAdditional prostate biopsyRetrospective cohort studyProstate MRILocalized prostate cancerRepeat prostate biopsyRate of biopsyRace/ethnicityCensus tract povertyMedian followCohort studyMedian ageMonitoring testsProvider factorsPSA testClinical riskBiopsySociodemographic factors
2018
MP12-15 NATIONAL TRENDS IN THE MANAGEMENT OF LOCALIZED PROSTATE CANCER FROM A POPULATION-BASED COHORT OF PRIVATELY INSURED PATIENTS
Kim S, Karnes J, Bukavina L, Van Houten H, Gross C, Mwangi R, Shah N. MP12-15 NATIONAL TRENDS IN THE MANAGEMENT OF LOCALIZED PROSTATE CANCER FROM A POPULATION-BASED COHORT OF PRIVATELY INSURED PATIENTS. Journal Of Urology 2018, 199: e141-e142. DOI: 10.1016/j.juro.2018.02.402.Peer-Reviewed Original Research
2017
PD09-02 RACIAL VARIATION IN THE REFUSAL OF INITIAL TREATMENT PLAN AMONG MEN DIAGNOSED WITH LOCALIZED PROSTATE CANCER
Scarberry K, Scarberry K, Abouassaly R, Gonzalez C, Gross C, Shah N, Meropol N, Psutka S, Prasad S, Bukavina L, Kim S. PD09-02 RACIAL VARIATION IN THE REFUSAL OF INITIAL TREATMENT PLAN AMONG MEN DIAGNOSED WITH LOCALIZED PROSTATE CANCER. Journal Of Urology 2017, 197: e194. DOI: 10.1016/j.juro.2017.02.552.Peer-Reviewed Original Research
2014
Erratum: Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer
Kim S, Gross C, Nguyen P, Smaldone M, Thompson R, Shah N, Kutikov A, Han L, Karnes R, Ziegenfuss J, Tilburt J. Erratum: Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer. Prostate Cancer And Prostatic Diseases 2014, 17: 212-212. DOI: 10.1038/pcan.2014.14.Peer-Reviewed Original ResearchProstate cancerLocalized prostate cancerPerceptions of radiation oncologists and urologists on the type of evidence that informs and changes the clinical practice of prostate cancer.
Delpe S, Shah N, Tilburt J, Karnes R, Nguyen P, Shuch B, Gross C, Schulam P, Yu J, Ziegenfuss J, Kim S. Perceptions of radiation oncologists and urologists on the type of evidence that informs and changes the clinical practice of prostate cancer. Journal Of Clinical Oncology 2014, 32: 167-167. DOI: 10.1200/jco.2014.32.4_suppl.167.Peer-Reviewed Original ResearchLevel of evidenceProstate cancerSpecialty-specific journalsRadiation oncologistsTreatment recommendationsClinical practiceClinical guidelinesMultivariable logistic regression modelLocalized prostate cancerNew treatment paradigmProstate cancer specialistsProstate cancer treatmentLogistic regression modelsNational survey studySurvey response ratePhysician characteristicsTreatment paradigmCancer specialistsResponse rateOncologistsUrologistsCancerCancer treatmentRCTsCancer journals